SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-22-005147
Filing Date
2022-04-12
Accepted
2022-04-12 16:07:31
Documents
13
Period of Report
2022-04-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 p482238k.htm   iXBRL 8-K 26533
2 EXHIBIG 10.1 ex10_1.htm EX-10.1 107873
  Complete submission text file 0001214659-22-005147.txt   335808

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hgen-20220412.xsd EX-101.SCH 3009
4 XBRL LABEL FILE hgen-20220412_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE hgen-20220412_pre.xml EX-101.PRE 22579
7 EXTRACTED XBRL INSTANCE DOCUMENT p482238k_htm.xml XML 3575
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 22822355
SIC: 2834 Pharmaceutical Preparations